Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Blood Specimen Collection × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 23 Neoplasms 19 Colorectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 8 Prostatic Neoplasms 6 Uterine Cervical Neoplasms 5 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Myelodysplastic Syndromes 5 Brain Neoplasms 5 Sarcoma 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Skin Neoplasms 3 Myeloproliferative Disorders 3 Multiple Myeloma 3 Melanoma 3 Kidney Neoplasms 3 Uveal Melanoma 2 Triple Negative Breast Neoplasms 2 Thrombosis 2 Neuroblastoma 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lung Diseases 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Esophageal Neoplasms 2

Interventions

Rituximab 21 Cyclophosphamide 11 Lenalidomide 9 zanubrutinib 7 venetoclax 6 orelabrutinib 6 obinutuzumab 6 fludarabine 6 pirtobrutinib 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Magnetic Resonance Spectroscopy 4 CT-P10 4 Bendamustine Hydrochloride 4 ibrutinib 3 Whole-Body Irradiation 3 Specimen Handling 3 Doxorubicin 3 acalabrutinib 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Cyclosporine 2 Biopsy 2 voruciclib 1 umbralisib 1 treosulfan 1 tislelizumab 1 tafasitamab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡